Surgical Science Sweden AB (publ)

PINK:SUSRF USA Health Information Services
Market Cap
$587.82 Million
Market Cap Rank
#10908 Global
#4967 in USA
Share Price
$11.52
Change (1 day)
-8.13%
52-Week Range
$11.52 - $14.39
All Time High
$36.80
About

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator … Read more

Surgical Science Sweden AB (publ) (SUSRF) - Total Liabilities

Latest total liabilities as of September 2025: $403.58 Million USD

Based on the latest financial reports, Surgical Science Sweden AB (publ) (SUSRF) has total liabilities worth $403.58 Million USD as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Surgical Science Sweden AB (publ) - Total Liabilities Trend (2014–2024)

This chart illustrates how Surgical Science Sweden AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Surgical Science Sweden AB (publ) Competitors by Total Liabilities

The table below lists competitors of Surgical Science Sweden AB (publ) ranked by their total liabilities.

Liability Composition Analysis (2014–2024)

This chart breaks down Surgical Science Sweden AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 4.18 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.09 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.09 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Surgical Science Sweden AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Surgical Science Sweden AB (publ) (2014–2024)

The table below shows the annual total liabilities of Surgical Science Sweden AB (publ) from 2014 to 2024.

Year Total Liabilities Change
2024-12-31 $651.03 Million +82.13%
2023-12-31 $357.46 Million -13.47%
2022-12-31 $413.11 Million +5.10%
2021-12-31 $393.06 Million +769.14%
2020-12-31 $45.22 Million -17.08%
2019-12-31 $54.54 Million +168.97%
2018-12-31 $20.28 Million +51.32%
2017-12-31 $13.40 Million -67.56%
2016-12-31 $41.30 Million +17.66%
2015-12-31 $35.10 Million +200.86%
2014-12-31 $11.67 Million --